1. Home
  2. BDSX vs ABEO Comparison

BDSX vs ABEO Comparison

Compare BDSX & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

N/A

Current Price

$26.63

Market Cap

276.2M

Sector

Health Care

ML Signal

N/A

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.85

Market Cap

399.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
ABEO
Founded
2005
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
276.2M
399.5M
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
BDSX
ABEO
Price
$26.63
$5.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$32.50
$20.00
AVG Volume (30 Days)
122.8K
1.5M
Earning Date
05-04-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
165.16
EPS
N/A
N/A
Revenue
$88,499,000.00
$2,998,000.00
Revenue This Year
$25.26
$1,024.31
Revenue Next Year
$19.15
$145.42
P/E Ratio
N/A
N/A
Revenue Growth
24.08
258.18
52 Week Low
$0.35
$4.00
52 Week High
$31.31
$7.65

Technical Indicators

Market Signals
Indicator
BDSX
ABEO
Relative Strength Index (RSI) 55.53 42.98
Support Level $19.26 $5.71
Resistance Level $31.31 $5.97
Average True Range (ATR) 2.56 0.18
MACD -0.18 -0.02
Stochastic Oscillator 51.91 29.63

Price Performance

Historical Comparison
BDSX
ABEO

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Share on Social Networks: